Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2011

Conditions

Parkinson's Disease

Interventions

DRUG

Rotigotine transdermal patch

8 mg/24 h, transdermal patch 8 mg/24 h, 2 days

Trial Locations (16)

Innsbruck

Vienna

Alzenau in Unterfranken

Berlin

Bochum

Böblingen

Cologne

Gera

Karlstadt am Main

Stuttgart

Wolfach

Blackpool

Derby

Liverpool

Newcastle upon Tyne

Norwich